BLEEDnFIRE Therapeutics

BLEEDnFIRE Therapeutics AG

BLEEDnFIRE Therapeutics was founded in 2025, is headquartered in Bern, Switzerland, and has 1 recorded funding round.

Headquarters
Bern
Founded
2025
Business Model
B2B
Last Round
GrantNov 2024
Rounds
1

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

BLEEDnFIRE Therapeutics is a Switzerland-based biotechnology company developing first-in-class siRNA therapeutics designed to rebalance coagulation across major bleeding disorders. Founded in 2025 as a University of Bern spin-off, the company is building on more than 15 years of hemostasis research centered on Protein S modulation, aiming to move beyond factor replacement and single-indication approaches to hemophilia and other rare bleeding disorders.

Summary

BLEEDnFIRE Therapeutics is a Biotech company based in Bern, Switzerland, founded in 2025. Its most recent funding was a Grant round in Nov 2024. Investors include Venture Kick.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantVenture Kick GrantNov 2024

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BLEEDnFIRE Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/bleednfire-therapeutics"><img src="https://indexed.vc/api/badge/company/bleednfire-therapeutics" alt="BLEEDnFIRE Therapeutics on Indexed.vc" width="260" height="76" /></a>